Press release
Pulmonary Arterial Hypertension (PAH) Market Is Projected To Accelerate At A CAGR Of 5.4% To Reach Us$ 13.5 Bn By 2031
The pulmonary arterial hypertension (PAH) market was valued at US$ 5.2 billion in 2020 and is expected to grow at a 5.4% CAGR to US$ 13.5 billion by 2028.
Over the forecast period, demand for endothelin receptor antagonists (ERAs) is expected to grow at a 5% CAGR.
Read Report Overview: https://www.factmr.com/report/pulmonary-arterial-hypertension-pah-market
Competitive Landscape
Strategic formulations such as new product development and commercialization, commercial expansion, and distribution partnerships are being implemented by prominent participants for business expansion. Furthermore, these leaders are investing heavily in product development, which is fueling revenue generation.
As an example,
Teva Pharmaceutical Industries Ltd. launched a generic version of Gilead's Letairis (ambrisentan) tablets in the United States in 2019. Ambrisentan, an endothelin receptor antagonist, is used to treat pulmonary arterial hypertension.
To remain 'ahead' of your competitors, request for a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7234
Key Segments Covered in Pulmonary Arterial Hypertension Industry Research
By Drug Class:
Prostacyclin & Prostacyclin Analogs
Endothelin Receptor Antagonists (ERAs)
Phosphodiesterase-5 (PDE-5) Inhibitors
Soluble Guanylate Cyclase (sGC) Stimulators
By Pipeline Analysis:
Early-stage Drug Candidates (Phase I & Phase II)
Late-stage Drug Candidates (Phase III & Registration Phase)
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Ask an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7234
Why is the market for pulmonary arterial hypertension in the United States expanding so quickly?
"The Presence of Board-Certified Physicians Increases Market Value"
Each year, pulmonary arterial hypertension causes over 200,000 hospitalizations in the United States. The availability of board-certified physicians, rising hospital admissions related to PAH, and the commercialization of new PAH medications, all accompanied by a promising pharmacological pipeline, are driving market growth in the United States.
Furthermore, the PAH market in the United States is expected to grow rapidly due to the rising prevalence of this illness as a result of heavy alcohol consumption, rapid adoption of a sedentary lifestyle, and rising smoking habits among individuals.
Pulmonary Arterial Hypertension (PAH) Market Competitive Analysis Market Report:
• Key players' strategies and products offered
• Potential and niche segments, geographical regions with promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and expand their market footprint
Choose Quick and Secure PayPal Payment Mode to Get Full Access to This Report: https://www.factmr.com/checkout/7234
Why Should You Use Fact.MR?
1. A variety of analysis methods to provide precise market information.
2. Use of digital technologies to provide clients with up-to-date market solutions.
3. A multidisciplinary approach to providing accurate insights into various industries.
4. Gathering data from extensive primary and secondary research.
5. Availability around the clock to serve clients all over the world.
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.
Over the forecast period, demand for endothelin receptor antagonists (ERAs) is expected to grow at a 5% CAGR.
Read Report Overview: https://www.factmr.com/report/pulmonary-arterial-hypertension-pah-market
Competitive Landscape
Strategic formulations such as new product development and commercialization, commercial expansion, and distribution partnerships are being implemented by prominent participants for business expansion. Furthermore, these leaders are investing heavily in product development, which is fueling revenue generation.
As an example,
Teva Pharmaceutical Industries Ltd. launched a generic version of Gilead's Letairis (ambrisentan) tablets in the United States in 2019. Ambrisentan, an endothelin receptor antagonist, is used to treat pulmonary arterial hypertension.
To remain 'ahead' of your competitors, request for a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7234
Key Segments Covered in Pulmonary Arterial Hypertension Industry Research
By Drug Class:
Prostacyclin & Prostacyclin Analogs
Endothelin Receptor Antagonists (ERAs)
Phosphodiesterase-5 (PDE-5) Inhibitors
Soluble Guanylate Cyclase (sGC) Stimulators
By Pipeline Analysis:
Early-stage Drug Candidates (Phase I & Phase II)
Late-stage Drug Candidates (Phase III & Registration Phase)
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Ask an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7234
Why is the market for pulmonary arterial hypertension in the United States expanding so quickly?
"The Presence of Board-Certified Physicians Increases Market Value"
Each year, pulmonary arterial hypertension causes over 200,000 hospitalizations in the United States. The availability of board-certified physicians, rising hospital admissions related to PAH, and the commercialization of new PAH medications, all accompanied by a promising pharmacological pipeline, are driving market growth in the United States.
Furthermore, the PAH market in the United States is expected to grow rapidly due to the rising prevalence of this illness as a result of heavy alcohol consumption, rapid adoption of a sedentary lifestyle, and rising smoking habits among individuals.
Pulmonary Arterial Hypertension (PAH) Market Competitive Analysis Market Report:
• Key players' strategies and products offered
• Potential and niche segments, geographical regions with promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and expand their market footprint
Choose Quick and Secure PayPal Payment Mode to Get Full Access to This Report: https://www.factmr.com/checkout/7234
Why Should You Use Fact.MR?
1. A variety of analysis methods to provide precise market information.
2. Use of digital technologies to provide clients with up-to-date market solutions.
3. A multidisciplinary approach to providing accurate insights into various industries.
4. Gathering data from extensive primary and secondary research.
5. Availability around the clock to serve clients all over the world.
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
